Cargando…
SHP2 Regulates Chondrocyte Terminal Differentiation, Growth Plate Architecture and Skeletal Cell Fates
Loss of PTPN11/SHP2 in mice or in human metachondromatosis (MC) patients causes benign cartilage tumors on the bone surface (exostoses) and within bones (enchondromas). To elucidate the mechanisms underlying cartilage tumor formation, we investigated the role of SHP2 in the specification, maturation...
Autores principales: | Bowen, Margot E., Ayturk, Ugur M., Kurek, Kyle C., Yang, Wentian, Warman, Matthew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038465/ https://www.ncbi.nlm.nih.gov/pubmed/24875294 http://dx.doi.org/10.1371/journal.pgen.1004364 |
Ejemplares similares
-
SHP2 Regulates the Osteogenic Fate of Growth Plate Hypertrophic Chondrocytes
por: Wang, Lijun, et al.
Publicado: (2017) -
SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity
por: Zuo, Chunlin, et al.
Publicado: (2018) -
Growth Plate Chondrocytes: Skeletal Development, Growth and Beyond
por: Hallett, Shawn A., et al.
Publicado: (2019) -
Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes
Publicado: (1993) -
SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth
por: Fornaro, Mara, et al.
Publicado: (2006)